A carregar...
Publicação
Topical Imiquimod Treatment of Lentigo Maligna
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 163.17 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Lentigo maligna (LM) is the in situ phase of lentigo maligna melanoma, which may progress to invasive melanoma if left untreated. It mainly occurs on sun-exposed areas of elderly patients. The lesions can be large and conventional surgery can be difficult, particularly on the face. Recent reports indicate that topical imiquimod 5% cream is effective in the treatment of LM. It may be an alternative when surgery or other classical treatments are not possible in elderly patients. We describe an 80-year-old Caucasian woman with a 10-year history of a histologically verified extensive LM of the face. She was treated with imiquimod 5% cream once daily. After four months it showed complete clinical response. One year after the treatment the patient was still free from recurrence.
Descrição
Palavras-chave
Neoplasias da Pele Lentigo Imiquimod
Contexto Educativo
Citação
Case Rep Dermatol. 2009;1(1):78-81.